Radioimmunoassay Market is valued around USD 398.19 Million in 2018 and expected to reach USD 496.92 Million by 2025 with the CAGR of 3.8% over the forecast period. Increased prevalence of cancer & infectious disease and increase in research activities are the key drivers for Global Radioimmunoassay Market. Radioimmunoassay is a medical diagnostic procedure used for the quantification of specific antigens and antibody. It is a very sensitive procedure which can also be used for the quantification of very small amount of biological substance. Radioimmunoassay is used for the early detection of cancer and various other diseases. It is also used for research purposes and in pharmaceutical industry for testing of drugs. So, during the study of global radioimmunoassay market, we have considered radioimmunoassay product type and application to analyze the market.
Global radioimmunoassay market report is segmented on the basis of product type, application type, end user and by regional & country level. Based upon product type, global radioimmunoassay market is classified as kits and reagents and analyzers. Based upon application, global radioimmunoassay market is classified as scientific research and medical diagnosis. Based upon end-user, global radioimmunoassay market is classified as hospitals, pharmaceutical and biotechnology industry, academic research institute and contract research organizations. The regions covered in this radioimmunoassay market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of radioimmunoassay is sub-divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Comments
Post a Comment